- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01760512
Clinical and Health Economic Impact of Robot-assisted Surgery vs Conventional Laparoscopy : the Case of Gastric Bypass
Prospective, Single-blind, Randomized, Non-inferiority, and Controlled Study of Clinical and Health Economic Impact of Robot-assisted Surgery Versus Conventional Laparoscopy in Bariatric Surgery: the Case of Gastric Bypass
The purpose of this study is to gather clinical and economic evidence on the use of robotics for bariatric surgery (gastric bypass).
This monocentric, randomized, single blind, controlled study will evaluate post-operative pain, quality of life and appetite, post-operative complication incidence. It will also provide information on direct and indirect costs of surgery.
Study Overview
Detailed Description
Robot-assisted Surgery Versus Conventional Laparoscopy in Bariatric Surgery (Gastric Bypass): a prospective, single-blind, randomized, non-inferiority, and controlled study The main evaluation criterion is 24h post-operative pain assessed using visual analog scale (VAS). Secondary criteria included for clinical assessment: post 24h pain, excess weight loss, quality of life, appetite, complications, conversion rate; and for health-economics assessment : duration of surgical steps, length of stay, return to normal activity and their conversion to cost, consumables, estimation of indirect costs and benefits (e.g., robotics perception, publication).
In this study, main inclusion criteria include major obesity (IMC ≥ 35) with co-morbidities or morbid obesity (IMC ≥ 40), scheduled gastric bypass surgery Main contraindications are previous bariatric surgery and previous major abdominal surgeries To test robotic-assisted surgery non-inferiority on VAS pain score 24h post-surgery, a total of 128 patients (64 per arm) is to be included (alpha 2,5%; power 90%; drop-out rate: 5%).
The study will include 12 months of follow-up post-surgery for each patient. The total study duration is 2 years and 3 months.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Strasbourg, France, 67 000
- Service de Chirurgie Digestive et Endocrinienne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient presenting with major obesity (BMI ≥ 35) with co-morbidities or morbid obesity (BMI ≥ 40)according to French HAS (Haute Autorité de Santé) and CNAMTS (Caisse nationale de l'assurance maladie des travailleurs salariés)criteria for whom gastric bypass is scheduled
- Male or female between 18 and 65 years old
- Patient registered with the French Social Security
- Patient having provided a written informed consent prior to enrolment
- Patient accepting to attend follow-up visits as required by study protocol
Exclusion Criteria:
- Patient with a BMI ≥ 60
- Patient with a contraindication for laparoscopic gastric bypass with or without robotic assistance
- Patient having had prior bariatric surgery
- Patient having had prior major abdominal surgery
- Patient in exclusion period of another clinical study
- Patient pregnant or breastfeeding
- Patient without sufficient knowledge of french language or unable to receive or understand study related information and answer to questionnaires
- Patient with no or limited legal capacity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Robot-assisted surgery
Robot-assisted (da Vinci surgical system) gastric bypass
|
Gastric bypass
|
Active Comparator: Conventional laparoscopy
Laparoscopic gastric bypass
|
Gastric bypass
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
24h postoperative pain
Time Frame: 24h
|
Pain assessment 24h post surgery (visual analog scale)
|
24h
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of post-operative pain
Time Frame: 24h, 8 days, 1, 3, 6 and 12 months
|
Evaluation of post-operative pain (beyond 24h post-operative) using VAS
|
24h, 8 days, 1, 3, 6 and 12 months
|
Evaluation of quality of life (BAROS and GIQLI)
Time Frame: At 1, 3, 6 and 12 months
|
Evaluation of quality of life using BAROS and GIQLI questionaires
|
At 1, 3, 6 and 12 months
|
Evaluation of appetite level
Time Frame: At 8 days, 1, 3, 6 and 12 months
|
Evaluation of appetite level using VAS
|
At 8 days, 1, 3, 6 and 12 months
|
Percentage of excess weight loss
Time Frame: At 8 days, 1, 3, 6 and 12 months
|
Measure of excess weight loss - % from baseline
|
At 8 days, 1, 3, 6 and 12 months
|
Conversion rate to conventional laparoscopy
Time Frame: During the procedure (Day 0)
|
Conversion rate to conventional laparoscopy (only applicable to robot-assisted surgery arm)
|
During the procedure (Day 0)
|
Nature of per-operative complications
Time Frame: During the procedure (Day 0)
|
Nature of per-operative complications
|
During the procedure (Day 0)
|
Nature of post-operative complications
Time Frame: Following the procedure (Day 0) up to 12 months
|
Nature of post-operative complications
|
Following the procedure (Day 0) up to 12 months
|
Evaluation of operative times
Time Frame: During the procedure (Day 0)
|
Evaluation of key steps of gastric bypass surgery, OR occupation time
|
During the procedure (Day 0)
|
Evaluation of direct costs
Time Frame: During the procedure (day 0) and up to 12 months
|
Direct costs include material used, OR occupation time, length of stay, return to normal activity
|
During the procedure (day 0) and up to 12 months
|
Evaluation of indirect costs
Time Frame: Up to 12 months
|
Combination of number of patients having surgery, perception of robot-assisted surgery by both personnel and patients, publications, and communications
|
Up to 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michel Vix, Service de Chirurgie Générale et Endocrinienne - Nouvel Hôpital Civil - Strasbourg
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Morbid Obesity
-
ClinTrio Ltd.UnknownMorbid Obesity Requiring Bariatric SurgeryBelgium, Germany, Portugal, Austria, Netherlands, Poland, Saudi Arabia
-
Centre Hospitalier Universitaire de NiceCompletedMorbid Obesity D009765France
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Hospices Civils de LyonCentre de Recherche en Nutrition Humaine Rhone-Alpe; Institut National de Recherche... and other collaboratorsRecruiting
-
Endolumik, IncWest Virginia UniversityNot yet recruitingMorbid ObesityUnited States
-
Rijnstate HospitalRecruiting
-
Laval UniversityCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie...Recruiting
-
University of WashingtonUnited States Department of DefenseWithdrawn
-
Helsinki University Central HospitalActive, not recruiting
-
IHU StrasbourgWithdrawnMorbid Obesity
Clinical Trials on Gastric bypass
-
Medical University of ViennaUnknown
-
Slotervaart HospitalAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)UnknownType 2 Diabetes Mellitus | Obesity, MorbidNetherlands
-
Puerta de Hierro University HospitalActive, not recruitingPostoperative Complications | Weight Loss | Morbid ObesitySpain
-
Puerta de Hierro University HospitalEnrolling by invitationPostoperative Complications | Weight Loss | Morbid ObesitySpain
-
Nemocnice Břeclav, p.o.UnknownDiabetes Mellitus, Type 2 | Obesity, SevereCzech Republic
-
Hospital Universitario Virgen de la ArrixacaUnknownObesity | Diabetes MellitusSpain
-
Kaunas University of MedicineUnknown
-
Ain Shams UniversitySuspended
-
Helsinki University Central HospitalActive, not recruiting
-
University Hospital, LilleCompletedObesity | Type 2 DiabetesFrance